Skip to content

Tooth Discoloration and Chairside Handling Time (Bonding-Debonding) in Flowable Versus Packable Composites for Clear Aligner Bonded Attachments: A Randomized Clinical Trial

Comparison of Color Stability, Bonding Time, and White Spot Lesion Between Flowable Nanocomposite and Packable Microhybrid Composite Used for Clear Aligner Attachments: A Split-Mouth Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07234149
Enrollment
20
Registered
2025-11-18
Start date
2025-10-15
Completion date
2026-12-16
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear Aligner Orthodontic Treatment, Color Stability of Enamel, Composite Attachment

Keywords

Composite Attachment Flowable Nanocomposite Packable Microhybrid Composite

Brief summary

This randomized split-mouth clinical trial aims to compare two different composite materials used for bonding attachments in clear aligner orthodontic therapy. Twenty adult participants with Class I malocclusion and mild crowding will receive flowable nanocomposite attachments on one side of the dental arch and packable microhybrid composite attachments on the opposite side. The primary outcome is the color change (ΔE) of the enamel surface after attachment removal, measured by a spectrophotometer (VITA Easyshade). Secondary outcomes include bonding and debonding time and changes in enamel surface roughness before and after treatment. The study will be conducted at the Orthodontic Department, College of Dentistry, University of Sulaimani. The goal is to determine which composite material provides better color stability, easier handling, and minimal impact on enamel surface characteristics during clear aligner therapy.

Detailed description

Clear aligner therapy has become a popular alternative to conventional fixed orthodontic appliances due to its superior esthetics and comfort. However, the efficiency of aligner treatment often depends on the proper use of composite attachments that enhance tooth movement and retention. Different composite resins are used for this purpose, but their optical stability and effect on enamel integrity after removal remain concerns. This prospective, split-mouth randomized clinical trial compares a flowable nanocomposite and a packable microhybrid composite used for clear aligner attachments. Each participant will receive both materials in opposite quadrants to minimize inter-individual variability. Outcomes will include enamel color change (ΔE CIE Lab\* values), bonding/debonding time, and surface roughness assessment using digital and optical analysis methods. The study hypothesis is that the flowable nanocomposite will exhibit superior color stability and faster handling time, with comparable enamel surface effects to the packable composite. Results from this trial may help establish standardized protocols for attachment material selection in clinical orthodontic practice.

Interventions

DEVICEflowable nanohybrid Composite Resin

A flowable nanocomposite (e.g., GC aligne connect) used to fabricate clear aligner attachments on enamel surfaces for comparison

DEVICEPackable Microhybrid Composite Resin

Packable microhybrid composite resin used to fabricate clear aligner attachments.

Sponsors

University of Sulaimani
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Single-blind design: the outcome assessor will be blinded to the type of composite used on each quadrant.

Intervention model description

Split-mouth randomized clinical trial in which each participant receives both interventions on opposite quadrants.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults 18-40 years. * patients with class l malocclusion with in which there treatment will be completed in 6 month . * Completed clear aligner therapy and scheduled for attachment debonding at the study clinic. * Permanent teeth with intact buccal enamel at assessment sites. * No caries, restorations, cracks, fluorosis, or hypoplasia on assessed surfaces. * No bleaching within 6 months prior to baseline. * Good general health (ASA I-II) and able to provide written informed consent. * Satisfactory oral hygiene and gingival health (e.g., GI ≤ 1). * Willing and able to complete measurements: spectrophotometric shade (CIE L\*, a\*, b\*), photographs/scans, and VAS for pain/discomfort. * Available for all visits and follow-up assessment.

Exclusion criteria

* Patients younger than 18 or older than 40 years. * Patients presenting with severe or very severe anterior crowding (LII \> 6 mm) or spacing will exclude from the study. Cases with posterior crossbites, open bites, or skeletal discrepancies * Presence of systemic diseases (ASA \> II) that may affect healing, pain perception, or enamel quality. * Teeth with caries, restorations, fractures, enamel cracks, fluorosis, hypoplasia, or discolorations on the buccal surfaces at assessment sites. * Patients who have undergone tooth bleaching within the last 6 months. * History of major dental surgery or trauma in the study region. * Patients with poor oral hygiene or gingival inflammation (GI \> 1). * Pregnant or lactating women. * Patients with allergy or hypersensitivity to composite resins or dental adhesives. * Individuals unable to provide informed consent or not willing to comply with study visits.

Design outcomes

Primary

MeasureTime frameDescription
Change in Tooth Color (ΔE) After Attachment RemovalBaseline (before bonding) and after attachment removalThe color change (ΔE) of the enamel surface will be measured using a VITA Easyshade spectrophotometer based on CIE Lab\* values before bonding and after debonding of the attachments. A ΔE value ≥ 3.3 will be considered clinically perceptible.

Countries

Iraq

Contacts

Primary ContactElaf Hussein Hasan H Hasan, BSD
elafhussein9494@gmail.com+9647715671612
Backup Contact. Hadi Mohammad M Ismail, PHD
hadi.ismail@univsul.edu.iq+9647702106211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026